Terminated PHASE3 INTERVENTIONAL 2-arm NCT03151863

Intranasal Dexmedetomidine for Procedural Pain Management in Elderly Adults in Palliative Care (INDEX)

Intranasal Dexmedetomidine for Procedural Pain Management in Elderly Adults in Palliative Care Setting: a Cross Over, Superiority, Double-blind, Controlled and Randomized Clinical Trial

Sponsor: Walid HABRE

Conditions Analgesia Anxiolysis Sedation

Interventions Dexmedetomidine Opioids Placebo

Updated 8 times since 2017 Last updated: Jul 20, 2021 Started: Nov 14, 2018 Primary completion: Jun 8, 2021 Completion: Jun 8, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Lack of budget

This PHASE3 trial investigates Analgesia and Anxiolysis and is currently terminated or withdrawn. Walid HABRE leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Sep 2021 — Jul 2024 [monthly]

Terminated PHASE3

Status: Recruiting → Terminated
Jan 2021 — Sep 2021 [monthly]

Recruiting PHASE3
May 2020 — Jan 2021 [monthly]

Recruiting PHASE3

▶ Show 3 earlier versions

Jun 2019 — May 2020 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting
Jun 2018 — Jun 2019 [monthly]

Not Yet Recruiting PHASE3
Jun 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Walid HABRE

Data source: University Hospital, Geneva

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Geneva, Switzerland